AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
DELISTED
Theravance Biopharma
TBPH
| $1.15M | ﹤0.01% |
70,600
+520
| +0.7% | +$8.61K |
2014 Q2
48 quarters
|
|
2327
Pacira BioSciences
PCRX
$1.45B
| $1.15M | ﹤0.01% |
50,693
-2,300
| -4% | -$54.4K |
2013 Q2
52 quarters
|
|
2328
Thomson Reuters
TRI
$53.4B
| $1.14M | ﹤0.01% |
13,971
-1,162
| -8% | -$101K |
2013 Q2
52 quarters
|
|
2329
Diversified Energy Company
DEC
$1.01B
| $1.13M | ﹤0.01% |
64,870
+15,700
| +32% | +$238K |
2023 Q4
10 quarters
|
|
2330
Maze Therapeutics
MAZE
$1.72B
| $1.13M | ﹤0.01% |
37,800
-26,962
| -42% | -$707K |
2025 Q1
5 quarters
|
|
2331
Viking Therapeutics
VKTX
$3.1B
| $1.12M | ﹤0.01% |
34,550
+7,881
| +30% | +$255K |
2023 Q1
13 quarters
|
|
2332
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.7B
| $1.12M | ﹤0.01% |
48,001
+746
| +2% | +$17.5K |
2025 Q3
3 quarters
|
|
2333
Array Technologies
ARRY
$491M
| $1.12M | ﹤0.01% |
154,504
-3,100
| -2% | -$24.7K |
2020 Q4
22 quarters
|
|
2334
McEwen Inc
MUX
$898M
| $1.11M | ﹤0.01% |
+54,600
| New | +$1.18M |
2026 Q2
0 quarters
|
|
2335
Sprinklr
CXM
$1.55B
| $1.11M | ﹤0.01% |
185,779
+6,840
| +4% | +$36.4K |
2023 Q2
12 quarters
|
|
2336
NCR Voyix
VYX
$1.16B
| $1.11M | ﹤0.01% |
175,964
-623
| -0.4% | -$4.38K |
2013 Q2
52 quarters
|
|
2337
Bicara Therapeutics
BCAX
$1.13B
| $1.11M | ﹤0.01% |
55,990
+24,160
| +76% | +$539K |
2025 Q2
4 quarters
|
|
2338
Gildan
GIL
$7.5B
| $1.11M | ﹤0.01% |
19,990
+1,578
| +9% | +$90.6K |
2013 Q2
52 quarters
|
|
2339
Enterprise Products Partners
EPD
$80.1B
| $1.11M | ﹤0.01% |
29,362
-287,900
| -91% | -$10.9M |
2024 Q1
9 quarters
|
|
2340
Goosehead Insurance
GSHD
$1.15B
| $1.11M | ﹤0.01% |
26,009
-4
| -0% | -$165 |
2018 Q3
31 quarters
|
|
2341
Taysha Gene Therapies
TSHA
$1.29B
| $1.11M | ﹤0.01% |
247,680
+58,440
| +31% | +$346K |
2024 Q2
8 quarters
|
|
2342
South Plains Financial
SPFI
$810M
| $1.11M | ﹤0.01% |
26,420
+14,790
| +127% | +$617K |
2024 Q2
8 quarters
|
|
2343
Amphastar Pharmaceuticals
AMPH
$1.07B
| $1.11M | ﹤0.01% |
56,430
| – | – |
2015 Q1
45 quarters
|
|
2344
Shoals Technologies Group
SHLS
$1.28B
| $1.1M | ﹤0.01% |
167,434
| – | – |
2021 Q1
21 quarters
|
|
2345
MFA Financial
MFA
$673M
| $1.1M | ﹤0.01% |
114,775
-100
| -0.1% | -$970 |
2013 Q2
52 quarters
|
|
2346
Navient
NAVI
$797M
| $1.1M | ﹤0.01% |
134,149
-13,940
| -9% | -$117K |
2014 Q2
48 quarters
|
|
2347
ICL Group
ICL
$6.16B
| $1.1M | ﹤0.01% |
211,763
+64,323
| +44% | +$366K |
2015 Q2
44 quarters
|
|
2348
Mercantile Bank Corp
MBWM
$1.06B
| $1.09M | ﹤0.01% |
21,561
+16
| +0.1% | +$844 |
2017 Q1
37 quarters
|
|
2349
Freedom Holding
FRHC
$10.9B
| $1.09M | ﹤0.01% |
7,497
+1,127
| +18% | +$164K |
2025 Q2
4 quarters
|
|
2350
Northeast Bank
NBN
$1.11B
| $1.08M | ﹤0.01% |
9,653
+2,890
| +43% | +$357K |
2018 Q4
30 quarters
|
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.